--2024/Q4-- / 1.098B--
--2024/Q3-- / 989.990M--
Jul 25, 20242024/Q21.004B / 1.037B--
--2024/Q1921.000M / 910.902M--
Feb 8, 20242023/Q41.035B / 1.022B--
US Stock MarketDetailed Quotes
DXCM DexCom
- 69.710
- +1.100+1.60%
Close Sep 9 16:00 ET
- 69.930
- +0.220+0.32%
Post 20:01 ET
27.93BMarket Cap43.30P/E (TTM)
71.560High68.740Low3.63MVolume68.870Open68.610Pre Close254.93MTurnover0.91%Turnover Ratio53.62P/E (Static)400.73MShares142.00052wk High11.47P/B27.72BFloat Cap62.34052wk Low--Dividend TTM397.66MShs Float164.863Historical High--Div YieldTTM4.11%Amplitude0.340Historical Low70.174Avg Price1Lot Size
DexCom Key Stats
DexCom Q2 2024 Earnings Date
Currency：USDJul 25, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 1.04B | 1.00B | -32.71M |
| Miss Est. | +19.02% | +15.26% | -3.15% |
| EPS | 0.38 | 0.35 | -0.03 |
| Miss Est. | +36.61% | +25.00% | -8.50% |
Analyst Rating
Sep 9, 2024
DexCom Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
DexCom Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
